Our US Grantees

william slayton

William B. Slayton, M.D.

University of Florida Targeting leukemic stem cells in infant leukemia by blocking interactions with the microenvironment...more

william matsui

William H. Matsui, M.D.

Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center Hedgehog signaling as a stem cell based therapeutic target in myelodysplastic syndrome and...more

William S. Blaner, Ph.D.

Columbia University, Institute of Human Nutrition Complementary Approaches for Treating Acute Lymphoblastic Leukemia (ALL): A Mouse ALL...more

xi jiang

Xi Jiang, Ph.D.

The Univ. of ChicagoThe Function and Regulatory Mechanism of miR-495 in Acute Myeloid Leukemia (AML)...more

xianzheng zhou

Xianzheng Zhou, M.D., Ph.D.

University of Minnesota Cancer Center T-Cell Gene Transfer and Therapy by the Sleeping Beauty Transposon System...more

xiaochun chen

Xiaochun Chen, Ph.D.

University of Maryland School of Medicine Development of drugs that downregulate microRNAs associated with drug resistance...more

xuefeng zhang

Xuefeng Zhang, M.D., Ph.D.

Beth Israel Deaconness Medical CenterTargeting Slit2/Robo4 Signaling as a Novel Treatment for Leukemia...more

yongkui jing

Yonkgui Jing, Ph.D.

Mount Sinai School of Medicine Therapeutic effect of Boswellia Carterri Birdw in Acute Myelocyctic Leukemia...more

kwon2

Young Jik Kwon, Ph.D.

University of California, Irvine Killing Two Birds with One Stone: Dual Modal Gene Therapy for Leukemia Using Chimeric Nanoparticles...more

zejuan li

Zejuan Li, M.D., Ph.D.

The University of Chicago The role of miR-126 in core-binding factor acute myeloid leukemia...more